Global Hospital Acquired Disease Testing Market Size, Status and Forecast 2021-2027

Hosptial infection is categorized based on infection types into the following segments: blood stream infection (BSI) testing, urinary tract infection (UTI) testing, methicilin-resistant staphylococcus aureus (MRSA) testing, pneumonia testing, surgical site infection (SSI) testing & others infections such as cardio vascular infection, gastrointestinal infections & respiratory infections.
One of the key factors driving industry growth is the rising geriatric population base. Advancing age of the geriatric population makes them more vulnerable and prone to diseases, thus increasing the demand for diagnosis. Other aspects supporting industry growth are growing demand of HAI diagnostics from middle and low-income countries such as India and Brazil, development of technologically advanced diagnostic products, rising awareness among healthcare workers, and initiatives taken by governments to counter the prevalence of HAIs. However, decreasing prevalence of nosocomial infections in the developed countries owing to improved healthcare infrastructure and rising awareness are expected to restrict industry growth.

Market Analysis and Insights: Global Hospital Acquired Disease Testing Market
The global Hospital Acquired Disease Testing market size is projected to reach US$ 969.2 million by 2027, from US$ 453.2 million in 2020, at a CAGR of 11.3% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hospital Acquired Disease Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hospital Acquired Disease Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hospital Acquired Disease Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hospital Acquired Disease Testing market.

Global Hospital Acquired Disease Testing Scope and Market Size
Hospital Acquired Disease Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hospital Acquired Disease Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Instrument and Reagents
Consumables

Segment by Application
Disease Testing
Drug-Resistance Testing

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Life technologies
Diatherix laboratories
Qiagen GmbH
Meridian Biosciences
Nordion
Roche
Cantel Medical Corporation
Cepheid

Frequently Asked Questions